Animal Parasiticides Market

研究執行與發布：MarketsandMarkets　·　發布日期 2026-02-13　·　439 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

完整報告名稱與涵蓋範圍

Animal Parasiticides Market by Type (Ectoparasiticide, Endoparasiticide, Endectocide, Spray, Feed Additives), Animal Type (Dog, Cat, Horse, Cattle, Pig, Poultry), End user (Hospital, Animal farm, Home Care Setting) & Region - Global Forecast to 2031

報告摘要

The animal parasiticides market is expected to grow from USD 12.98 billion in 2026 to USD 17.50 billion by 2031, at a CAGR of 6.2%. This growth is driven by several key factors shaping the future of parasite prevention, including long-acting treatment solutions and precision-driven parasite management in veterinary care. One of the most significant driving forces in the animal parasiticides market is the growing demand for more effective, targeted, and preventive parasite control strategies as veterinary healthcare professionals work to improve the accuracy, speed, and longevity of parasite control. As the trend in the companion animal healthcare industry continues to evolve to a data-driven and risk-based approach to parasite control, there is an increasing demand for high-quality parasiticides that can support precision dosing, resistance, and year-round protection. This has been further fueled by the use of analytics and digital health platforms, thus creating a demand for innovative and safe parasiticide products. Pet owners face urgent demand for fast-acting, effective, and long-lasting solutions because parasite infestations, vector-borne diseases, and age-related pet vulnerability keep increasing in frequency. Veterinarians use advanced oral, topical, and injectable products to treat more patients while achieving better treatment results through reduced need for patient follow-ups. The rising parasite resistance problem and environmental parasite contamination issue compel scientists to develop new active ingredients and combination parasiticides for their research. Formulation science and delivery system advancements, such as extended-release injectables, long-acting oral chewables, and enhanced topical formulations, are driving the market as they enhance efficacy, ease of use, and compliance. Such advancements enable effective preventive treatment, close treatment gaps, and improve real-world outcomes, thus accelerating the ongoing development and adoption of innovative solutions in the animal parasiticides market. "By animal type, the companion animals segment is projected to exhibit a higher CAGR than the livestock segment during the forecast period." The companion animals segment is expected to experience a high growth rate in the animal parasiticides market because of the rising number of pet owners, the increasing humanization of pets, and increased expenditures on preventive veterinary care. The growing awareness of parasite-borne diseases, combined with the strong adoption of year-round flea, tick, and heartworm prevention and innovative long-acting parasiticide products, has also fueled demand in this segment. "By end user, the veterinary hospitals & clinics segment accounted for the largest market share in 2025." In 2025, the veterinary hospitals & clinics segment dominated the animal parasiticides market because these facilities served as the main center for parasite control treatment delivery through their diagnostic and prescription capabilities. Pet owners and livestock producers depend on veterinarians to deliver expert product advice and preventive care solutions, which leads to increased sales of parasiticides at veterinary clinics. The combination of prescription-only products and advanced long-acting products, together with rising demand for routine check-ups and preventive care, has established veterinary hospitals and clinics as the primary distribution and treatment channel in the market. “Latin America is expected to witness the highest growth rate during the forecast period.” Latin America is projected to be the fastest-growing regional market for animal parasiticides during the forecast period. The region's high market growth can be attributed to the expansion of livestock production, the increase in companion animal ownership, and a growing awareness of parasite prevention and animal health. Year-round favorable parasite living conditions due to the region's climate, enhanced availability of veterinary services, and increased use of modern parasiticide products are all factors that are speeding up the market growth in the Latin American region. Breakdown of supply-side primary interviews: • By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%) • By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%) • By Region: North America (45%), Europe (15%), Asia Pacific (25%), Latin America (10%), and the Middle East & Africa (5%) Breakdown of demand-side primary interviews: • By End User: Veterinary Hospitals & Clinics (50%), Animal Farms (33%), and Home Care Settings (17%) By Designation: Veterinarian/Chief Veterinary Officer (47%), Procurement/Purchasing Manager (22%), Head of Animal Health / Farm Manager (15%), and Others (16%) • By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%) Research Coverage The market study covers the animal parasiticides market in various segments. It aims to estimate the size and growth potential of this market by type, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies. Reasons to Buy the Report The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below. This report provides insights into the following points: • Analysis of key drivers (rising pet ownership and increased focus on preventive animal healthcare and growing prevalence of ecto- and endoparasites), restraints (strict regulations on parasiticide residues in food-producing animals and high cost of premium and combination parasiticide products), opportunities (development of long-acting, combination, and novel-delivery parasiticides and expansion of parasiticide adoption in emerging markets), and challenges (increasing parasite resistance to existing active ingredients and stringent regulatory approval processes and varying regional compliance requirements) influencing the growth of the animal parasiticides market. • Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the animal parasiticides market. • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of animal parasiticide products across regions. • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the animal parasiticides market. • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the animal parasiticides market.

授權報價

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

目錄 Table of Contents

1 INTRODUCTION 37 1.1 STUDY OBJECTIVES 37 1.2 MARKET DEFINITION 37 1.3 MARKET SCOPE 38 1.3.1 MARKETS COVERED 38 1.3.2 INCLUSIONS AND EXCLUSIONS 39 1.3.3 YEARS CONSIDERED 39 1.4 CURRENCY 39 1.5 STAKEHOLDERS 40 2 EXECUTIVE SUMMARY 42 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 42 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 43 2.3 DISRUPTIVE TRENDS IN ANIMAL PARASITICIDES MARKET 44 2.4 HIGH-GROWTH SEGMENTS 45 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 46 3 PREMIUM INSIGHTS 47 3.1 ANIMAL PARASITICIDES MARKET OVERVIEW 47 3.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE AND COUNTRY (2025) 48 3.3 ANIMAL PARASITICIDES MARKET: REGIONAL GROWTH OPPORTUNITIES 49 3.4 ANIMAL PARASITICIDES MARKET: REGION (2026−2031) 49 3.5 ANIMAL PARASITICIDES MARKET: DEVELOPED VS. DEVELOPING ECONOMIES 50 4 MARKET OVERVIEW 51 4.1 INTRODUCTION 51 4.2 MARKET DYNAMICS 51 4.2.1 DRIVERS 52 4.2.1.1 Increasing zoonotic & vector-borne disease burden, creating mandatory treatment 52 4.2.1.2 Expanding companion animal population and pet ownership 53 4.2.1.3 Increasing demand for animal-derived food products 55 4.2.2 RESTRAINTS 57 4.2.2.1 Growing resistance to parasiticides 57 4.2.2.2 Stringent regulatory approval processes for veterinary drugs 58 4.2.3 OPPORTUNITIES 59 4.2.3.1 High growth potential of emerging economies 59 4.2.4 CHALLENGES 60 4.2.4.1 Uneven regulatory approval timelines across key markets, creating access inequalities 60 4.2.4.2 Balancing animal welfare, productivity, and compliance requirements 60 4.3 UNMET NEEDS AND WHITE SPACES 61 4.4 INTERCONNECTED MARKET AND CROSS-SECTOR OPPORTUNITIES 62 4.4.1 INTERCONNECTED MARKETS 62 4.4.2 CROSS-SECTOR OPPORTUNITIES 63 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 63 4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 63 5 INDUSTRY TRENDS 64 5.1 PORTER’S FIVE FORCE ANALYSIS 64 5.1.1 THREAT OF NEW ENTRANTS 65 5.1.2 THREAT OF SUBSTITUTES 65 5.1.3 BARGAINING POWER OF SUPPLIERS 65 5.1.4 BARGAINING POWER OF BUYERS 66 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 66 5.2 MACROECONOMIC INDICATORS 67 5.2.1 INTRODUCTION 67 5.2.2 GDP TRENDS AND FORECAST 67 5.2.3 GDP, CURRENT PRICES (BILLIONS OF U.S. DOLLARS) 67 5.2.4 GDP: CURRENT PRICES (USD BILLION) 67 5.2.5 TRENDS IN GLOBAL ANIMAL HEALTHCARE INDUSTRY 68 5.2.6 TRENDS IN GLOBAL ANIMAL PARASITICIDES INDUSTRY 69 5.3 VALUE CHAIN ANALYSIS 69 5.4 ECOSYSTEM ANALYSIS 71 5.5 PRICING ANALYSIS 71 5.5.1 AVERAGE SELLING PRICE TREND OF ANIMAL PARASITICIDES, BY KEY PLAYER, 2023–2025 72 5.5.1.1 Average selling price trend of ectoparasiticides, by key player, 2023−2025 72 5.5.1.2 Average selling price trend of endoparasiticides, by key player, 2023−2025 73 5.5.1.3 Average selling price trend of endectocides, by key player, 2023−2025 74 5.5.2 AVERAGE SELLING PRICE TREND OF ANIMAL PARASITICIDES, BY REGION, 2023–2025 75 5.5.2.1 Average selling price trend of pour-on ectoparasiticides (USD per standard treatment unit), by region, 2023−2025 76 5.5.2.2 Average selling price trend of spray ectoparasiticides (USD per standard treatment unit), by region, 2023−2025 77 5.5.2.3 Average selling price trend of tablet ectoparasiticides (USD per standard treatment unit), by region, 2023−2025 77 5.5.2.4 Average selling price trend of endoparasiticide oral solids (USD per standard treatment unit), by region, 2023−2025 77 5.5.2.5 Average selling price trend of injectable endectocides (USD per standard treatment unit), by region, 2023−2025 78 5.6 TRADE ANALYSIS 78 5.6.1 IMPORT DATA FOR HS CODE 30, 2021–2025 78 5.6.2 IMPORT SCENARIO (HS CODE 30) 78 5.6.3 EXPORT DATA FOR HS CODE 30, 2021–2025 79 5.6.4 EXPORT SCENARIO (HS CODE 30) 79 5.7 KEY CONFERENCES AND EVENTS IN 2026–2027 80 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 81 5.9 INVESTMENT AND FUNDING SCENARIO 81 5.10 CASE STUDY ANALYSIS 82 5.10.1 CASE STUDY 1: BROAD-SPECTRUM COMBINATION ECTOPARASITICIDE + ENDOPARASITICIDE (ZOETIS – SIMPARICA TRIO) 82 5.10.2 CASE STUDY 2: FIRST BROAD-SPECTRUM FELINE TOPICAL ENDECTOCIDE (BOEHRINGER INGELHEIM – NEXGARD COMBO) 83 5.10.3 CASE STUDY 3: BROADEST-SPECTRUM CANINE ORAL PARASITICIDE WITH FOUR ACTIVE INGREDIENTS (ELANCO – CREDELIO QUATTRO) 83 5.11 ANIMAL PARASITICIDES MARKET: IMPACT OF 2025 US TARIFF 84 5.11.1 INTRODUCTION 84 5.11.2 KEY TARIFF RATES 85 5.11.3 PRICE IMPACT ANALYSIS 85 5.11.4 IMPACT ON COUNTRY/REGION 86 5.11.5 IMPACT ON END USERS 89 5.11.5.1 Veterinary hospitals & clinics 89 5.11.5.2 Home care settings 89 5.11.5.3 Animal farms 89 6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION 90 6.1 TECHNOLOGY ANALYSIS 90 6.1.1 KEY EMERGING TECHNOLOGIES 90 6.1.1.1 Long-acting/Extended-release parasiticides 90 6.1.1.2 Novel multi-parasite combination therapies 91 6.1.2 COMPLEMENTARY TECHNOLOGIES 91 6.1.2.1 Immunomodulators for host-assisted parasitic control 91 6.1.2.2 Nanobiosensors and rapid diagnostics for parasitic detection 92 6.1.3 ADJACENT TECHNOLOGIES 92 6.1.3.1 Entomopathogenic Fungi (EPF) for ticks and ectoparasites 92 6.1.3.2 Precision livestock farming sensors and wearables 93 6.2 TECHNOLOGY/PRODUCT ROADMAP 93 6.3 PATENT ANALYSIS 95 6.3.1 PUBLICATION TRENDS FOR ANIMAL PARASITICIDES 95 6.3.1.1 Insights on patent publication trends, top applicants and jurisdiction for animal parasiticides, january 2015–may 2026 95 6.3.2 LIST OF MAJOR PATENTS, 2023–2026 97 6.4 FUTURE APPLICATIONS 98 6.4.1 PRECISION LIVESTOCK HEALTH MANAGEMENT 98 6.4.2 ONCOLOGY AND CHRONIC DISEASE MANAGEMENT 98 6.4.3 REPRODUCTIVE AND FERTILITY ENHANCEMENT IN LIVESTOCK 98 6.4.4 INTEGRATED DISEASE SURVEILLANCE AND OUTBREAK CONTROL 98 6.5 IMPACT OF AI/GENERATIVE AI ON ANIMAL PARASITICIDES MARKET 99 6.5.1 INTRODUCTION 99 6.5.2 MARKET POTENTIAL IN ANIMAL PARASITICIDES ECOSYSTEM 99 6.5.3 AI USE CASES 100 6.5.4 KEY COMPANIES IMPLEMENTING AI IN ANIMAL PARASITICIDES MARKET 100 7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 102 7.1 DECISION-MAKING PROCESS 102 7.2 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA 103 7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 103 7.2.2 BUYING CRITERIA 105 7.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 106 7.4 UNMET NEEDS IN VARIOUS END-USE SETTINGS 107 7.4.1 VETERINARY HOSPITALS & CLINICS 107 7.4.2 LIVESTOCK FARMS 107 7.4.3 HOME CARE SETTINGS 108 7.5 MARKET PROFITABILITY 108 7.5.1 PRODUCT INNOVATION AND DIFFERENTIATION 108 7.5.2 EXPANSION OF COMPANION ANIMAL HEALTHCARE SPENDING 108 7.5.3 OPERATIONAL SCALE AND DISTRIBUTION EFFICIENCY 108 8 SUSTAINABILITY AND REGULATORY LANDSCAPE 109 8.1 REGULATORY LANDSCAPE 109 8.1.1 REGULATORY FRAMEWORK 109 8.1.1.1 North America 109 8.1.1.2 Europe 109 8.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 8.1.3 INDUSTRY STANDARDS 113 8.1.3.1 VICH Guidelines (International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products) 113 8.1.3.2 Good Manufacturing Practice (GMP) Standards – PIC/S Guide (PE 009 series) 113 8.1.3.3 Codex Alimentarius Standards for Veterinary Drug Residues (CXM 2 – Maximum Residue Limits) 113 8.2 SUSTAINABILITY INITIATIVES 113 8.2.1 ENERGY-EFFICIENT MANUFACTURING & CARBON REDUCTION IN ANIMAL PARASITICIDES MARKET 113 8.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 114 8.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 115 9 ANIMAL PARASITICIDES MARKET, BY TYPE 116 9.1 INTRODUCTION 117 9.2 ECTOPARASITICIDES 118 9.2.1 POUR-ONS & SPOT-ONS 121 9.2.1.1 Ease of application and broad spectrum activity to drive continued adoption 121 9.2.1.2 Global volume analysis of pour-ons & spot-ons, 2024–2031 (Thousand Units) 122 9.2.2 ORAL TABLETS 124 9.2.2.1 High medication compliance and ease of administration to drive market 124 9.2.2.2 Global Volume Analysis of oral tablets, 2024–2031 (Thousand Units) 125 9.2.3 SPRAYS 126 9.2.3.1 Low price and convenience to drive market in emerging economies and livestock sector 126 9.2.3.2 Global Volume Analysis of sprays, 2024–2031 (Thousand Units) 127 9.2.4 DIPS 128 9.2.4.1 High popularity ensures sustained end-user demand 128 9.2.4.2 Global Volume Analysis of DIPS, 2024–2031 (Thousand Units) 129 9.2.5 EAR TAGS 131 9.2.5.1 High effectiveness in controlling flies around cattle drives market 131 9.2.5.2 Global Volume Analysis of ear tags, 2024–2031 (Thousand Units) 132 9.2.6 COLLARS 133 9.2.6.1 Growing prevalence of infections in companion animals to drive adoption 133 9.2.6.2 Global Volume Analysis of collars market, 2024–2031 (Thousand Units) 134 9.2.7 OTHER ECTOPARASITICIDES 135 9.3 ENDOPARASITICIDES 136 9.3.1 ORAL LIQUIDS 139 9.3.1.1 Broad-spectrum activity to drive adoption across young animals and intensive livestock systems 139 9.3.1.2 Global volume analysis of oral liquids, 2024–2031 (Thousand Units) 140 9.3.2 ORAL SOLIDS 142 9.3.2.1 Emergence of internal parasitic infections in dogs to drive market 142 9.3.2.2 Global volume analysis of oral solids, 2024–2031 (Thousand Units) 143 9.3.3 INJECTABLES 144 9.3.3.1 Global volume analysis of injectables, 2024–2031 (Thousand Units) 144 9.3.3.2 Standard/Short-acting injectables 146 9.3.3.2.1 Veterinary preference for fast-acting injectable formulations in acute parasitic infections drives market growth 146 9.3.3.3 Long-acting/Extended-release injectables 148 9.3.3.3.1 Emergence of internal parasitic infections in dogs to drive market 148 9.3.4 FEED ADDITIVES 149 9.3.4.1 Can be administered to large number of animals at once 149 9.3.4.2 Global volume analysis of feed additives, 2024–2031 (Thousand Units) 150 9.3.5 OTHER ENDOPARASITICIDES 152 9.4 ENDECTOCIDES 153 9.4.1 ORAL ENDECTOCIDES 155 9.4.1.1 Growing pet owner preference for systemic all-in-one protection to accelerate oral endectocide demand 155 9.4.1.2 Global volume analysis of oral endectocides, 2024–2031 (Thousand Units) 156 9.4.2 INJECTABLE ENDECTOCIDES 158 9.4.2.1 Single-injection dual-action convenience underpins dominance in cattle and swine production systems 158 9.4.2.2 Global volume analysis of injectable endectocides, 2024–2031 (Thousand Units) 159 9.4.3 TOPICAL ENDECTOCIDES 160 9.4.3.1 Convenience, zero-injection compliance, and expanding multi-spectrum topical formulations sustain demand 160 9.4.3.2 Global volume analysis of topical endectocides, 2024–2031 (Thousand Units) 161 10 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE 163 10.1 INTRODUCTION 164 10.2 COMPANION ANIMALS 164 10.2.1 DOGS 167 10.2.1.1 Increasing adoption of dogs to drive market growth 167 10.2.2 CATS 169 10.2.2.1 Rising feline parasiticide adoption, low preventive compliance, and broad-spectrum product launches drive growth 169 10.2.3 HORSES 170 10.2.3.1 Higher risk of traumatic injuries in horses to drive demand 170 10.2.4 OTHER COMPANION ANIMALS 172 10.3 LIVESTOCK ANIMALS 173 10.3.1 CATTLE 176 10.3.1.1 Gastrointestinal nematodes and tick-borne disease drive systemic endectocide and acaricide demand 176 10.3.2 PIG 177 10.3.2.1 Growing surgical volume for acute conditions in swine to drive market growth 177 10.3.3 POULTRY 178 10.3.3.1 Growing focus on infection prevention and flock health management propels growth 178 10.3.4 SHEEP & GOAT 180 10.3.4.1 Growth in consumption of sheep and goat meat to drive market 180 10.3.5 OTHER LIVESTOCK ANIMALS 181 11 ANIMAL PARASITICIDES MARKET, BY END USER 183 11.1 INTRODUCTION 184 11.2 VETERINARY HOSPITALS & CLINICS 184 11.2.1 VETERINARY HOSPITALS & CLINICS TO DOMINATE MARKET DURING FORECAST PERIOD 184 11.3 ANIMAL FARMS 186 11.3.1 GROWING IMPORTANCE AND OPPORTUNITIES IN ON-FARM PARASITE MANAGEMENT 186 11.4 HOME CARE SETTINGS 187 11.4.1 RISING PET EXPENDITURE TO PROPEL MARKET GROWTH 187 12 ANIMAL PARASITICIDES MARKET, BY REGION 189 12.1 INTRODUCTION 190 12.2 NORTH AMERICA 191 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 191 12.2.2 NORTH AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS) 193 12.2.3 US 197 12.2.3.1 Surge in animal healthcare expenditure to boost market growth 197 12.2.4 CANADA 202 12.2.4.1 Growing pet ownership and increasing focus on preventive animal healthcare to drive market growth 202 12.3 EUROPE 205 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 206 12.3.2 EUROPE: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS) 207 12.3.3 GERMANY 211 12.3.3.1 Strong focus on animal welfare and advanced veterinary care to drive market growth 211 12.3.4 UK 215 12.3.4.1 Increasing pet ownership and rising animal healthcare spending to propel market growth 215 12.3.5 FRANCE 219 12.3.5.1 High standards of veterinary care and technological advancements to support market growth 219 12.3.6 ITALY 223 12.3.6.1 Growing pet ownership awareness and increasing livestock population to drive market growth 223 12.3.7 SPAIN 227 12.3.7.1 Increasing awareness regarding animal health to drive market growth 227 12.3.8 NETHERLANDS 230 12.3.8.1 Growing pet ownership and strong livestock sector to support market growth 230 12.3.9 SWEDEN 234 12.3.9.1 Growing companion animal care and advanced veterinary infrastructure supporting market growth 234 12.3.10 POLAND 238 12.3.10.1 Rapid expansion of poultry production and export-oriented farming increases demand 238 12.3.11 REST OF EUROPE 242 12.4 ASIA PACIFIC 245 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 245 12.4.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS) 248 12.4.3 CHINA 252 12.4.3.1 China to register highest growth rate during forecast period 252 12.4.4 JAPAN 256 12.4.4.1 Rising pet care expenditure and increasing adoption of companion animals to drive market growth 256 12.4.5 INDIA 259 12.4.5.1 Increasing livestock population to propel market growth 259 12.4.6 AUSTRALIA 263 12.4.6.1 Growing companion animal ownership and rise in animal health awareness to support market growth 263 12.4.7 SOUTH KOREA 267 12.4.7.1 Growing pet ownership to favor growth 267 12.4.8 THAILAND 270 12.4.8.1 Growing focus on livestock health and disease prevention to drive market growth 270 12.4.9 NEW ZEALAND 274 12.4.9.1 Growing pet ownership and focus on preventive animal healthcare to support market growth 274 12.4.10 REST OF ASIA PACIFIC 278 12.5 LATIN AMERICA 282 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 282 12.5.2 LATIN AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS) 283 12.5.3 BRAZIL 287 12.5.3.1 Brazil to dominate Latin American market 287 12.5.4 MEXICO 291 12.5.4.1 Robust livestock base and growing companion animal care drive market 291 12.5.5 ARGENTINA 294 12.5.5.1 Expanding livestock production and increasing focus on disease prevention to drive market growth 294 12.5.6 REST OF LATIN AMERICA 298 12.6 MIDDLE EAST & AFRICA 302 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 302 12.6.2 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS) 303 12.7 GCC COUNTRIES 307 12.7.1 KINGDOM OF SAUDI ARABIA (KSA) 311 12.7.1.1 Market growth driven by Vision 2030 investments 311 12.7.2 UNITED ARAB EMIRATES (UAE) 314 12.7.2.1 Increasing focus on livestock health and companion animal care to support market growth 314 12.7.3 OTHER GCC COUNTRIES 318 12.7.4 REST OF MIDDLE EAST & AFRICA 322 13 COMPETITIVE LANDSCAPE 326 13.1 INTRODUCTION 326 13.1.1 KEY STRATEGIES ADOPTED BY PLAYERS IN ANIMAL PARASITICIDES MARKET 326 13.2 REVENUE ANALYSIS, 2023–2025 328 13.3 GLOBAL MARKET SHARE ANALYSIS, 2025 328 13.3.1 US ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025 331 13.3.2 EUROPE ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025 331 13.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 332 13.4.1 STARS 332 13.4.2 EMERGING LEADERS 332 13.4.3 PERVASIVE PLAYERS 332 13.4.4 PARTICIPANTS 332 13.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 334 13.4.5.1 Company footprint 334 13.4.5.2 Region footprint 335 13.4.5.3 Product type footprint 336 13.4.5.4 Animal type footprint 337 13.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 338 13.5.1 PROGRESSIVE COMPANIES 338 13.5.2 RESPONSIVE COMPANIES 338 13.5.3 DYNAMIC COMPANIES 338 13.5.4 STARTING BLOCKS 338 13.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 340 13.5.5.1 List of startups/SMEs 340 13.5.5.2 Competitive benchmarking of startups/SMEs 341 13.6 COMPANY VALUATION AND FINANCIAL METRICS 342 13.7 PRODUCT/BRAND COMPARISON 343 13.8 COMPETITIVE SITUATIONS & TRENDS 344 14 COMPANY PROFILES 347 14.1 KEY PLAYERS 347 14.1.1 ZOETIS INC. 347 14.1.1.1 Business overview 347 14.1.1.2 Products offered 349 14.1.1.3 Recent developments 349 14.1.1.3.1 Product launches & approvals 349 14.1.1.3.2 Expansions 350 14.1.1.3.3 Other developments 351 14.1.1.4 MnM view 351 14.1.1.4.1 Right to win 351 14.1.1.4.2 Strategic choices 351 14.1.1.4.3 Weaknesses and competitive threats 352 14.1.2 MERCK & CO., INC 353 14.1.2.1 Business overview 353 14.1.2.2 Products offered 354 14.1.2.3 Recent developments 356 14.1.2.3.1 Product launches & approvals 356 14.1.2.3.2 Deals 357 14.1.2.3.3 Expansions 357 14.1.2.4 MnM view 357 14.1.2.4.1 Right to win 357 14.1.2.4.2 Strategic choices 358 14.1.2.4.3 Weaknesses and competitive threats 358 14.1.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 359 14.1.3.1 Business overview 359 14.1.3.2 Products offered 360 14.1.3.3 Recent developments 361 14.1.3.3.1 Product launches & approvals 361 14.1.3.3.2 Deals 362 14.1.3.3.3 Expansions 362 14.1.3.4 MnM view 363 14.1.3.4.1 Right to win 363 14.1.3.4.2 Strategic choices 363 14.1.3.4.3 Weaknesses and competitive threats 363 14.1.4 ELANCO 364 14.1.4.1 Business overview 364 14.1.4.2 Products offered 365 14.1.4.3 Recent developments 367 14.1.4.3.1 Product launches & approvals 367 14.1.4.3.2 Expansions 368 14.1.4.3.3 Other developments 369 14.1.4.4 MnM view 369 14.1.4.4.1 Right to win 369 14.1.4.4.2 Strategic choices 369 14.1.4.4.3 Weaknesses and competitive threats 370 14.1.5 VIRBAC 371 14.1.5.1 Business overview 371 14.1.5.2 Products offered 373 14.1.5.3 Recent developments 374 14.1.5.3.1 Product launches & approvals 374 14.1.5.3.2 Deal 374 14.1.5.4 MnM view 374 14.1.5.4.1 Right to win 374 14.1.5.4.2 Strategic choices 375 14.1.5.4.3 Weaknesses and competitive threats 375 14.1.6 CEVA 376 14.1.6.1 Business overview 376 14.1.6.2 Products offered 376 14.1.6.3 Recent developments 377 14.1.6.3.1 Deals 377 14.1.6.3.2 Expansions 378 14.1.7 VETOQUINOL 379 14.1.7.1 Business overview 379 14.1.7.2 Products offered 381 14.1.8 NORBROOK 382 14.1.8.1 Business overview 382 14.1.8.2 Products offered 382 14.1.8.3 Recent developments 383 14.1.8.3.1 Product launches & approvals 383 14.1.8.3.2 Expansions 384 14.1.9 BIMEDA CORPORATE 385 14.1.9.1 Business overview 385 14.1.9.2 Products offered 385 14.1.9.3 Recent developments 386 14.1.9.3.1 Product launches & approvals 386 14.1.9.3.2 Deals 386 14.1.9.3.3 Expansions 387 14.1.10 KYORITSU SEIYAKU CORPORATION 388 14.1.10.1 Business overview 388 14.1.10.2 Products offered 388 14.1.11 KRKA, D. D., NOVO MESTO 390 14.1.11.1 Business overview 390 14.1.11.2 Products offered 391 14.1.12 ECO - ANIMAL HEALTH LTD. 393 14.1.12.1 Business overview 393 14.1.12.2 Products offered 394 14.1.13 ALIVIRA ANIMAL HEALTH LIMITED 395 14.1.13.1 Business overview 395 14.1.13.2 Products offered 395 14.1.13.2.1 Recent developments 396 14.1.13.2.2 Deals 396 14.1.14 OUROFINO SAÚDE ANIMAL 397 14.1.14.1 Business overview 397 14.1.14.2 Products offered 398 14.1.15 HEBEI VEYONG PHARMACEUTICAL CO., LTD. 399 14.1.15.1 Business overview 399 14.1.15.2 Products offered 399 14.2 OTHER PLAYERS 401 14.2.1 CHANELLE PHARMA 401 14.2.2 PETIQ LLC 402 14.2.3 HUVEPHARMA 403 14.2.4 CALIER 404 14.2.5 ABBEY LABS 405 14.2.6 BIOGÉNESIS BAGÓ 406 14.2.7 VETANCO SA 407 14.2.8 HESTER BIOSCIENCES LIMITED 408 14.2.9 BRILLIANT BIO PHARMA 409 14.2.10 ASHISH LIFE SCIENCE 410 15 RESEARCH METHODOLOGY 412 15.1 RESEARCH APPROACH 412 15.2 RESEARCH METHODOLOGY DESIGN 412 15.2.1 SECONDARY RESEARCH 413 15.2.1.1 Key data from secondary sources 414 15.2.2 PRIMARY DATA 414 15.2.2.1 Key data from primary sources 415 15.2.2.2 Key industry insights 416 15.3 MARKET SIZE ESTIMATION 418 15.3.1 APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 418 15.3.2 APPROACH 2: COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 420 15.3.3 APPROACH 3: DEMAND-SIDE ANALYSIS 420 15.3.4 APPROACH 4: TOP-DOWN APPROACH 421 15.3.5 APPROACH 5: BOTTOM-UP APPROACH 422 15.4 MARKET BREAKDOWN & DATA TRIANGULATION 425 15.5 MARKET SHARE ESTIMATION 425 15.6 RESEARCH ASSUMPTIONS 426 15.7 RISK ASSESSMENT 426 15.8 RESEARCH LIMITATIONS 427 15.8.1 METHODOLOGY-RELATED LIMITATIONS 427 15.8.2 SCOPE-RELATED LIMITATIONS 427 16 APPENDIX 428 16.1 DISCUSSION GUIDE 428 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 434 16.3 CUSTOMIZATION OPTIONS 436 16.3.1 PRODUCT ANALYSIS 436 16.3.2 COMPANY INFORMATION 436 16.3.3 GEOGRAPHIC ANALYSIS 436 16.3.4 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT 436 16.3.5 BY TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS) 436 16.3.6 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 436 16.4 RELATED REPORTS 437 16.5 AUTHOR DETAILS 438

圖表清單 List of Tables & Figures

TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD) 39 TABLE 2 PET (DOGS AND CATS) OWNERSHIP STATISTICS IN US, 2025 53 TABLE 3 COMPANION ANIMAL POPULATION STATISTICS, BY REGION 54 TABLE 4 TRENDS IN CONSUMPTION OF MEAT & MILK IN DEVELOPED & EMERGING ECONOMIES 56 TABLE 5 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 56 TABLE 6 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 57 TABLE 7 PARASITICIDES AND RESISTANT PARASITES 58 TABLE 8 UNMET CUSTOMER NEEDS AND WHITE SPACES IN ANIMAL PARASITICIDES MARKET. 61 TABLE 9 INTERCONNECTED MARKETS IN ANIMAL PARASITICIDES MARKET 62 TABLE 10 CROSS-SECTOR MARKETS IN ANIMAL PARASITICIDES MARKET 63 TABLE 11 ANIMAL PARASITICIDES MARKET: PORTER’S FIVE FORCES ANALYSIS 64 TABLE 12 AVERAGE SELLING PRICE TREND OF ECTOPARASITICIDES, BY KEY PLAYER, 2023–2025 72 TABLE 13 AVERAGE SELLING PRICE TREND OF ENDOPARASITICIDES, BY KEY PLAYER, 2023–2025 73 TABLE 14 AVERAGE SELLING PRICE TREND OF ENDECTOCIDES, BY KEY PLAYER, 2023–2025 74 TABLE 15 AVERAGE SELLING PRICE TREND OF POUR-ON ECTOPARASITICIDES, BY REGION, 2023−2025 76 TABLE 16 AVERAGE SELLING PRICE TREND OF SPRAY ECTOPARASITICIDES, BY REGION, 2023−2025 77 TABLE 17 AVERAGE SELLING PRICE TREND OF TABLET ECTOPARASITICIDES, BY REGION, 2023−2025 77 TABLE 18 AVERAGE SELLING PRICE TREND OF ENDOPARASITICIDE ORAL SOLIDS, BY REGION, 2023−2025 77 TABLE 19 AVERAGE SELLING PRICE TREND OF INJECTABLE ENDECTOCIDES, BY REGION, 2023−2025 78 TABLE 20 IMPORT DATA FOR HS CODE 30, BY COUNTRY, 2021–2025 (USD THOUSAND) 78 TABLE 21 EXPORT DATA FOR HS CODE 30, BY COUNTRY, 2021–2025 (USD THOUSAND) 79 TABLE 22 ANIMAL PARASITICIDES MARKET: KEY CONFERENCES AND EVENTS 80 TABLE 23 US ADJUSTED RECIPROCAL TARIFF RATES 85 TABLE 24 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS 86 TABLE 25 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 87 TABLE 26 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 88 TABLE 27 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS 88 TABLE 28 ANIMAL PARASITICIDES MARKET: MAJOR PATENTS, JANUARY 2022–MAY 2026 97 TABLE 29 KEY COMPANIES IMPLEMENTING AI IN ANIMAL PARASITICIDES MARKET 101 TABLE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL PARASITICIDES 104 TABLE 31 KEY BUYING CRITERIA FOR CLASS OF DEVICES 105 TABLE 32 ANIMAL PARASITICIDES MARKET: UNMET NEEDS IN KEY END-USE SETTINGS 107 TABLE 33 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 34 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 35 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112 TABLE 36 REST OF WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112 TABLE 37 ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 117 TABLE 38 COMPANION ANIMALS – FLEA & TICK BURDEN 118 TABLE 39 ECTOPARASITICIDES AVAILABLE IN MARKET 119 TABLE 40 ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 120 TABLE 41 ECTOPARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 120 TABLE 42 KEY PLAYERS PROVIDING POUR-ONS & SPOT-ONS 122 TABLE 43 GLOBAL VOLUME ANALYSIS OF POUR-ONS & SPOT-ONS, 2024–2031 (THOUSAND UNITS) 122 TABLE 44 POUR-ONS & SPOT-ONS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 45 KEY PLAYERS PROVIDING ORAL TABLETS 124 TABLE 46 GLOBAL VOLUME ANALYSIS OF ORAL TABLETS, 2024–2031 (THOUSAND UNITS) 125 TABLE 47 ORAL TABLETS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 48 KEY PLAYERS PROVIDING SPRAYS 126 TABLE 49 GLOBAL VOLUME ANALYSIS OF SPRAYS, 2024–2031 (THOUSAND UNITS) 127 TABLE 50 SPRAYS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 51 KEY PLAYERS PROVIDING DIPS 129 TABLE 52 GLOBAL VOLUME ANALYSIS OF DIPS, 2024–2031 (THOUSAND UNITS) 129 TABLE 53 DIPS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130 TABLE 54 KEY PLAYERS PROVIDING TAGS 131 TABLE 55 GLOBAL VOLUME ANALYSIS OF EAR TAGS, 2024–2031 (THOUSAND UNITS) 132 TABLE 56 EARTAG: ANIMAL PARASITICIDES TAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 57 KEY PLAYERS PROVIDING COLLARS 133 TABLE 58 GLOBAL VOLUME ANALYSIS OF COLLARS MARKET, 2024–2031 (THOUSAND UNITS) 134 TABLE 59 COLLARS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 60 OTHER ECTOPARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 61 ENDOPARASITICIDES AVAILABLE IN MARKET 137 TABLE 62 ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 138 TABLE 63 ENDOPARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 64 KEY PLAYERS PROVIDING ORAL LIQUIDS 139 TABLE 65 GLOBAL VOLUME ANALYSIS OF ORAL LIQUIDS, 2024–2031 (THOUSAND UNITS) 140 TABLE 66 ORAL LIQUIDS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 67 KEY PLAYERS PROVIDING ORAL SOLIDS 142 TABLE 68 GLOBAL VOLUME ANALYSIS OF ORAL SOLIDS, 2024–2031 (THOUSAND UNITS) 143 TABLE 69 ORAL: ANIMAL PARASITICIDES SOLIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 70 GLOBAL VOLUME ANALYSIS OF INJECTABLES, 2024–2031 (THOUSAND UNITS) 144 TABLE 71 INJECTABLES: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 145 TABLE 72 INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 73 KEY PLAYERS PROVIDING STANDARD/SHORT-ACTING INJECTABLES 146 TABLE 74 STANDARD/SHORT-ACTING INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 75 KEY PLAYERS PROVIDING LONG-ACTING/EXTENDED-RELEASE INJECTABLES 148 TABLE 76 LONG-ACTING/EXTENDED-RELEASE INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 77 KEY PLAYERS PROVIDING FEED ADDITIVES 149 TABLE 78 GLOBAL VOLUME ANALYSIS OF FEED ADDITIVES, 2024–2031 (THOUSAND UNITS) 150 TABLE 79 FEED ADDITIVES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 80 OTHER ENDOPARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 81 EXAMPLES OF ENDECTOCIDES AVAILABLE IN MARKET 153 TABLE 82 ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 154 TABLE 83 ENDECTOCIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 84 KEY PLAYERS PROVIDING ORAL ENDECTOCIDES 156 TABLE 85 GLOBAL VOLUME ANALYSIS OF ORAL ENDECTOCIDES, 2024–2031 (THOUSAND UNITS) 156 TABLE 86 ORAL ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 87 KEY PLAYERS PROVIDING INJECTABLE ENDECTOCIDES 158 TABLE 88 GLOBAL VOLUME ANALYSIS OF INJECTABLE ENDECTOCIDES, 2024–2031 (THOUSAND UNITS) 159 TABLE 89 INJECTABLE ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 90 KEY PLAYERS PROVIDING TOPICAL ENDECTOCIDES 160 TABLE 91 GLOBAL VOLUME ANALYSIS OF TOPICAL ENDECTOCIDES, 2024–2031 (THOUSAND UNITS) 161 TABLE 92 TOPICAL ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 93 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 164 TABLE 94 ANIMAL PARASITICIDES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 165 TABLE 95 ANIMAL PARASITICIDES MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 96 ANIMAL PARASITICIDES MARKET FOR DOGS, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 97 ANIMAL PARASITICIDES MARKET FOR CATS, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 98 ANIMAL PARASITICIDES MARKET FOR HORSES, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 99 PARASITICIDE APPLICATIONS ACROSS OTHER COMPANION ANIMAL SPECIES 172 TABLE 100 ANIMAL PARASITICIDES MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 101 ANIMAL PARASITICIDES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 174 TABLE 102 ANIMAL PARASITICIDES MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 103 ANIMAL PARASITICIDES MARKET FOR CATTLE, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 104 ANIMAL PARASITICIDES MARKET FOR PIG, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 105 ANIMAL PARASITICIDES MARKET FOR POULTRY, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 106 ANIMAL PARASITICIDES MARKET FOR SHEEP & GOAT, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 107 ANIMAL PARASITICIDES MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 108 ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 184 TABLE 109 ANIMAL PARASITICIDES MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 110 ANIMAL PARASITICIDES MARKET FOR ANIMAL FARMS, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 111 ANIMAL PARASITICIDES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 112 ANIMAL PARASITICIDES MARKET, BY REGION, 2024–2031 (USD MILLION) 191 TABLE 113 NORTH AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS) 193 TABLE 114 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 115 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 194 TABLE 116 NORTH AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 117 NORTH AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 118 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 195 TABLE 119 NORTH AMERICA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 196 TABLE 120 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 196 TABLE 121 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 196 TABLE 122 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 197 TABLE 123 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 197 TABLE 124 US: KEY MACROINDICATORS 198 TABLE 125 US: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 126 US: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 127 US: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 128 US: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 200 TABLE 129 US: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 200 TABLE 130 US: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 200 TABLE 131 US: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 201 TABLE 132 US: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 201 TABLE 133 US: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 201 TABLE 134 CANADA: KEY MACROINDICATORS 202 TABLE 135 CANADA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 202 TABLE 136 CANADA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 203 TABLE 137 CANADA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 203 TABLE 138 CANADA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 203 TABLE 139 CANADA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 204 TABLE 140 CANADA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 204 TABLE 141 CANADA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 204 TABLE 142 CANADA ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 205 TABLE 143 CANADA ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 205 TABLE 144 EUROPE: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS) 207 TABLE 145 EUROPE: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 146 EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 147 EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 148 EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 149 EUROPE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 209 TABLE 150 EUROPE: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 210 TABLE 151 EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 210 TABLE 152 EUROPE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 210 TABLE 153 EUROPE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 211 TABLE 154 EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 211 TABLE 155 GERMANY: KEY MACROINDICATORS 212 TABLE 156 GERMANY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 212 TABLE 157 GERMANY: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 158 GERMANY: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 159 GERMANY: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 213 TABLE 160 GERMANY: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 161 GERMANY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 214 TABLE 162 GERMANY ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 214 TABLE 163 GERMANY: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 215 TABLE 164 GERMANY: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 215 TABLE 165 UK: KEY MACROINDICATORS 216 TABLE 166 UK: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 216 TABLE 167 UK: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 217 TABLE 168 UK: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 217 TABLE 169 UK: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 217 TABLE 170 UK: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 171 UK: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 218 TABLE 172 UK: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 218 TABLE 173 UK: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 219 TABLE 174 UK ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 219 TABLE 175 FRANCE: KEY MACROINDICATORS 220 TABLE 176 FRANCE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 177 FRANCE: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 178 FRANCE: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 179 FRANCE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 221 TABLE 180 FRANCE: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 181 FRANCE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 222 TABLE 182 FRANCE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 222 TABLE 183 FRANCE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 222 TABLE 184 FRANCE: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 223 TABLE 185 ITALY: KEY MACROINDICATORS 223 TABLE 186 ITALY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 187 ITALY: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 188 ITALY: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 189 ITALY: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 225 TABLE 190 ITALY: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 225 TABLE 191 ITALY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 225 TABLE 192 ITALY: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 226 TABLE 193 ITALY: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 226 TABLE 194 ITALY: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 226 TABLE 195 SPAIN: KEY MACROINDICATORS 227 TABLE 196 SPAIN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 227 TABLE 197 SPAIN: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 228 TABLE 198 SPAIN: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 228 TABLE 199 SPAIN: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 228 TABLE 200 SPAIN: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 229 TABLE 201 SPAIN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 229 TABLE 202 SPAIN: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 229 TABLE 203 SPAIN: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 230 TABLE 204 SPAIN: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 230 TABLE 205 NETHERLANDS: KEY MACROINDICATORS 231 TABLE 206 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 231 TABLE 207 NETHERLANDS: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 208 NETHERLANDS: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 209 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 232 TABLE 210 NETHERLANDS: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 233 TABLE 211 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 233 TABLE 212 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 233 TABLE 213 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 234 TABLE 214 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 234 TABLE 215 SWEDEN: KEY MACRO INDICATORS 235 TABLE 216 SWEDEN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 235 TABLE 217 SWEDEN: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 235 TABLE 218 SWEDEN: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 219 SWEDEN: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 236 TABLE 220 SWEDEN: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 221 SWEDEN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 237 TABLE 222 SWEDEN: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 237 TABLE 223 SWEDEN: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 237 TABLE 224 SWEDEN: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 238 TABLE 225 POLAND: KEY MACRO INDICATORS 238 TABLE 226 POLAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 227 POLAND: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 228 POLAND: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 229 POLAND: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 240 TABLE 230 POLAND: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 240 TABLE 231 POLAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 240 TABLE 232 POLAND: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 241 TABLE 233 POLAND ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 241 TABLE 234 POLAND: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 241 TABLE 235 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 236 REST OF EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 237 REST OF EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 238 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 243 TABLE 239 REST OF EUROPE: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 240 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 244 TABLE 241 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 244 TABLE 242 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 244 TABLE 243 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 245 TABLE 244 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS) 248 TABLE 245 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 246 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 247 ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 248 ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 249 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 250 TABLE 250 ASIA PACIFIC: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 251 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 250 TABLE 252 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 251 TABLE 253 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 251 TABLE 254 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 251 TABLE 255 CHINA: KEY MACROINDICATORS 252 TABLE 256 CHINA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 253 TABLE 257 CHINA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 253 TABLE 258 CHINA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 253 TABLE 259 CHINA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 254 TABLE 260 CHINA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 261 CHINA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 254 TABLE 262 CHINA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 255 TABLE 263 CHINA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 255 TABLE 264 CHINA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 255 TABLE 265 JAPAN: KEY MACROINDICATORS 256 TABLE 266 JAPAN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 267 JAPAN: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 268 JAPAN: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 269 JAPAN: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 257 TABLE 270 JAPAN: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 258 TABLE 271 JAPAN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 258 TABLE 272 JAPAN ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 258 TABLE 273 JAPAN: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 259 TABLE 274 JAPAN: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 259 TABLE 275 INDIA: KEY MACROINDICATORS 260 TABLE 276 INDIA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 260 TABLE 277 INDIA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 278 INDIA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 279 INDIA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 261 TABLE 280 INDIA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 281 INDIA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 262 TABLE 282 INDIA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 262 TABLE 283 INDIA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 263 TABLE 284 INDIA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 263 TABLE 285 AUSTRALIA: KEY MACROINDICATORS 264 TABLE 286 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 287 AUSTRALIA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 288 AUSTRALIA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 289 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 265 TABLE 290 AUSTRALIA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 291 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 266 TABLE 292 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 266 TABLE 293 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 266 TABLE 294 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 267 TABLE 295 SOUTH KOREA: KEY MACROINDICATORS 267 TABLE 296 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 297 SOUTH KOREA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 298 SOUTH KOREA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 299 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 268 TABLE 300 SOUTH KOREA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 301 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 269 TABLE 302 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 269 TABLE 303 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 270 TABLE 304 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 270 TABLE 305 THAILAND: KEY MACROINDICATORS 271 TABLE 306 THAILAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 307 THAILAND: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 308 THAILAND: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 309 THAILAND: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 272 TABLE 310 THAILAND: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 311 THAILAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 273 TABLE 312 THAILAND: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 273 TABLE 313 THAILAND: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 274 TABLE 314 THAILAND: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 274 TABLE 315 NEW ZEALAND: KEY MACROINDICATORS 275 TABLE 316 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 317 NEW ZEALAND: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 318 NEW ZEALAND: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 319 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 276 TABLE 320 NEW ZEALAND: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 321 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 277 TABLE 322 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 277 TABLE 323 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 278 TABLE 324 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 278 TABLE 325 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 326 REST OF ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 327 REST OF ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 328 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 280 TABLE 329 REST OF ASIA PACIFIC: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 330 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 281 TABLE 331 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 281 TABLE 332 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 281 TABLE 333 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 282 TABLE 334 LATIN AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS) 283 TABLE 335 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 284 TABLE 336 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 337 LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 338 LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 339 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 285 TABLE 340 LATIN AMERICA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 341 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 286 TABLE 342 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 286 TABLE 343 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 286 TABLE 344 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 287 TABLE 345 BRAZIL: KEY MACROINDICATORS 287 TABLE 346 BRAZIL: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 347 BRAZIL: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 348 BRAZIL: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 349 BRAZIL: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 289 TABLE 350 BRAZIL: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 351 BRAZIL: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 289 TABLE 352 BRAZIL: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 290 TABLE 353 BRAZIL: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 290 TABLE 354 BRAZIL: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 290 TABLE 355 MEXICO: KEY MACROINDICATORS 291 TABLE 356 MEXICO: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 357 MEXICO: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 358 MEXICO: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 359 MEXICO: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 292 TABLE 360 MEXICO: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 361 MEXICO: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 293 TABLE 362 MEXICO: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 293 TABLE 363 MEXICO: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 294 TABLE 364 MEXICO: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 294 TABLE 365 ARGENTINA: KEY MACROINDICATORS 295 TABLE 366 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 367 ARGENTINA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 368 ARGENTINA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 369 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 296 TABLE 370 ARGENTINA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 371 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 297 TABLE 372 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 297 TABLE 373 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 298 TABLE 374 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 298 TABLE 375 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 376 REST OF LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 377 REST OF LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 378 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 300 TABLE 379 REST OF LATIN AMERICA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 380 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 301 TABLE 381 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 301 TABLE 382 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 301 TABLE 383 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 302 TABLE 384 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS) 303 TABLE 385 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 303 TABLE 386 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 387 MIDDLE EAST & AFRICA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 388 MIDDLE EAST & AFRICA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 389 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 305 TABLE 390 MIDDLE EAST & AFRICA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 391 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 306 TABLE 392 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 306 TABLE 393 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 306 TABLE 394 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 307 TABLE 395 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 307 TABLE 396 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 397 GCC COUNTRIES: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 398 GCC COUNTRIES: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 399 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 309 TABLE 400 GCC COUNTRIES: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 309 TABLE 401 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 309 TABLE 402 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 310 TABLE 403 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 310 TABLE 404 GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 310 TABLE 405 KINGDOM OF SAUDI ARABIA (KSA): KEY MACROINDICATORS 311 TABLE 406 KSA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 311 TABLE 407 KSA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 408 KSA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 409 KSA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 312 TABLE 410 KSA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 411 KSA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 313 TABLE 412 KSA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 313 TABLE 413 KSA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 314 TABLE 414 KSA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 314 TABLE 415 UNITED ARAB EMIRATES (UAE): KEY MACROINDICATORS 315 TABLE 416 UAE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 315 TABLE 417 UAE: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 315 TABLE 418 UAE: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 316 TABLE 419 UAE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 316 TABLE 420 UAE: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 316 TABLE 421 UAE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 317 TABLE 422 UAE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 317 TABLE 423 UAE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 317 TABLE 424 UAE: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 318 TABLE 425 OTHER GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 426 OTHER GCC COUNTRIES: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 427 OTHER GCC COUNTRIES: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 428 OTHER GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 320 TABLE 429 OTHER GCC COUNTRIES: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 430 OTHER GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 320 TABLE 431 OTHER GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 321 TABLE 432 OTHER GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 321 TABLE 433 OTHER GCC COUNTRIES: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 321 TABLE 434 REST OF MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 435 REST OF MIDDLE EAST & AFRICA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 436 REST OF MIDDLE EAST & AFRICA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 437 REST OF MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION) 323 TABLE 438 REST OF MIDDLE EAST & AFRICA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 439 REST OF MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 324 TABLE 440 REST OF MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION) 324 TABLE 441 REST OF MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION) 324 TABLE 442 REST OF MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION) 325 TABLE 443 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ANIMAL PARASITICIDES MARKET 326 TABLE 444 ANIMAL PARASITICIDES MARKET: DEGREE OF COMPETITION 329 TABLE 445 ANIMAL PARASITICIDES MARKET: REGION FOOTPRINT 335 TABLE 446 PRODUCT TYPE FOOTPRINT 336 TABLE 447 ANIMAL TYPE FOOTPRINT 337 TABLE 448 ANIMAL PARASITICIDES MARKET: LIST OF STARTUPS/SMES 340 TABLE 449 ANIMAL PARASITICIDES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 341 TABLE 450 ANIMAL PARASITICIDES MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2022–MAY 2026) 344 TABLE 451 ANIMAL PARASITICIDES MARKET: DEALS (JANUARY 2022–MAY 2026) 345 TABLE 452 ANIMAL PARASITICIDES MARKET: EXPANSIONS (JANUARY 2022–MAY 2026) 346 TABLE 453 ANIMAL PARASITICIDES MARKET: OTHER DEVELOPMENTS (JANUARY 2022–MAY 2026) 346 TABLE 454 ZOETIS INC.: COMPANY OVERVIEW 347 TABLE 455 ZOETIS INC.: PRODUCTS OFFERED 349 TABLE 456 ZOETIS, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2026 349 TABLE 457 ZOETIS, INC.: EXPANSIONS, JANUARY 2022- MAY 2026 350 TABLE 458 ZOETIS, INC.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026 351 TABLE 459 MERCK & CO., INC.: COMPANY OVERVIEW 353 TABLE 460 MERCK & CO., INC.: PRODUCTS OFFERED 354 TABLE 461 MERCK & CO., INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2026 356 TABLE 462 MERCK & CO., INC: DEALS, JANUARY 2022–MAY 2026 357 TABLE 463 MERCK & CO., INC: EXPANSIONS, JANUARY 2022–MAY 2026 357 TABLE 464 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW 359 TABLE 465 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED 360 TABLE 466 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2026 361 TABLE 467 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: DEALS, JANUARY 2022–MAY 2026 362 TABLE 468 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: EXPANSIONS, JANUARY 2022–MAY 2026 362 TABLE 469 ELANCO: COMPANY OVERVIEW 364 TABLE 470 ELANCO: PRODUCTS OFFERED 365 TABLE 471 ELANCO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2026 367 TABLE 472 ELANCO: EXPANSIONS, JANUARY 2022–MAY 2026 368 TABLE 473 ELANCO: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026 369 TABLE 474 VIRBAC: COMPANY OVERVIEW 371 TABLE 475 VIRBAC: PRODUCTS OFFERED 373 TABLE 476 VIRBAC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2026 374 TABLE 477 VIRBAC: DEALS, JANUARY 2022–MAY 2026 374 TABLE 478 CEVA: COMPANY OVERVIEW 376 TABLE 479 CEVA: PRODUCTS OFFERED 376 TABLE 480 CEVA: DEALS, JANUARY 2022–MAY 2026 377 TABLE 481 CEVA: EXPANSIONS, JANUARY 2022–MAY 2026 378 TABLE 482 VETOQUINOL: COMPANY OVERVIEW 379 TABLE 483 VETOQUINOL: PRODUCTS OFFERED 381 TABLE 484 NORBROOK: COMPANY OVERVIEW 382 TABLE 485 NORBROOK: PRODUCTS OFFERED 382 TABLE 486 NORBROOK: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022 - MAY 2026 383 TABLE 487 NORBROOK: EXPANSIONS, JANUARY 2022–MAY 2026 384 TABLE 488 BIMEDA CORPORATE: COMPANY OVERVIEW 385 TABLE 489 BIMEDA CORPORATE: PRODUCTS OFFERED 385 TABLE 490 BIMEDA CORPORATE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2026 386 TABLE 491 BIMEDA CORPORATE: DEALS, JANUARY 2022–MAY 2026 386 TABLE 492 BIMEDA CORPORATE: EXPANSIONS, JANUARY 2022–MAY 2026 387 TABLE 493 KYORITSU SEIYAKU CORPORATION: COMPANY OVERVIEW 388 TABLE 494 KYORITSU SEIYAKU CORPORATION: PRODUCTS OFFERED 388 TABLE 495 KRKA, D. D., NOVO MESTO: COMPANY OVERVIEW 390 TABLE 496 KRKA, D. D., NOVO MESTO: PRODUCTS OFFERED 391 TABLE 497 ECO - ANIMAL HEALTH LTD.: COMPANY OVERVIEW 393 TABLE 498 ECO - ANIMAL HEALTH LTD.: PRODUCTS OFFERED 394 TABLE 499 ALIVIRA ANIMAL HEALTH LIMITED: COMPANY OVERVIEW 395 TABLE 500 ALIVIRA ANIMAL HEALTH LIMITED: PRODUCTS OFFERED 395 TABLE 501 ALIVIRA ANIMAL HEALTH LIMITED: DEALS, JANUARY 2022–MAY 2026 396 TABLE 502 OUROFINO SAÚDE ANIMAL: COMPANY OVERVIEW 397 TABLE 503 OUROFINO SAÚDE ANIMAL: PRODUCTS OFFERED 398 TABLE 504 HEBEI VEYONG PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW 399 TABLE 505 HEBEI VEYONG PHARMACEUTICAL CO., LTD: PRODUCTS OFFERED 399 TABLE 506 ANIMAL PARASITICIDES MARKET: ASSUMPTIONS ANALYSIS 426 TABLE 507 ANIMAL PARASITICIDES MARKET: RISK ASSESSMENT ANALYSIS 426 FIGURE 1 ANIMAL PARASITICIDES MARKET SEGMENTATION 38 FIGURE 2 MARKET SCENARIO 42 FIGURE 3 GLOBAL ANIMAL PARASITICIDES MARKET, 2024–2031 43 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ANIMAL PARASITICIDES MARKET, 2022–2025 43 FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF ANIMAL PARASITICIDES MARKET 44 FIGURE 6 HIGH-GROWTH SEGMENTS IN ANIMAL PARASITICIDES MARKET, 2026–2031 45 FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN ANIMAL PARASITICIDES MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 46 FIGURE 8 INCREASING PET CARE EXPENDITURE TO DRIVE MARKET 47 FIGURE 9 ECTOPARASITICIDES AND CHINA DOMINATED MARKET IN 2025 48 FIGURE 10 ASIA PACIFIC TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD 49 FIGURE 11 MARKET IN CHINA TO GROW AT HIGHEST CAGR 49 FIGURE 12 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 50 FIGURE 13 ANIMAL PARASITICIDES MARKET DYNAMICS 51 FIGURE 14 PET POPULATION IN MAJOR MARKETS IN 2022 (MILLION) 53 FIGURE 15 EUROPE: PET POPULATION, 2021–2023 55 FIGURE 16 ANIMAL PARASITICIDES MARKET: PORTER’S FIVE FORCES ANALYSIS 64 FIGURE 17 ANIMAL PARASITICIDES MARKET: VALUE CHAIN ANALYSIS 70 FIGURE 18 ANIMAL PARASITICIDES MARKET: ECOSYSTEM ANALYSIS 71 FIGURE 19 AVERAGE SELLING PRICE OF ORAL ENDECTOCIDES, BY KEY PLAYER, 2025 75 FIGURE 20 AVERAGE SELLING PRICE OF ECTOPARASITICIDES, BY REGION, 2025 76 FIGURE 21 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 81 FIGURE 22 INVESTMENT/VENTURE CAPITAL SCENARIO IN ANIMAL PARASITICIDES MARKET, 2020–2024 82 FIGURE 23 ANIMAL PARASITICIDES: PATENT PUBLICATION TRENDS, JURISDICTION, AND TOP APPLICANT ANALYSIS 96 FIGURE 24 TOP APPLICANT COUNTRIES/REGIONS FOR ANIMAL PARASITICIDES (JANUARY 2015–MAY 2026) 97 FIGURE 25 AI USE CASES 100 FIGURE 26 AI DIAGNOSTIC PERFORMANCE IN PARASITE DETECTION 101 FIGURE 27 ANIMAL PARASITICIDES MARKET: DECISION-MAKING FACTORS 102 FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL PARASITICIDE PRODUCTS 103 FIGURE 29 KEY BUYING CRITERIA FOR TOP THREE END USERS 105 FIGURE 30 ADOPTION BARRIERS & INTERNAL CHALLENGES 106 FIGURE 31 GLOBAL LIVESTOCK POPULATION BY SPECIES — FAO FAOSTAT, 2024 (BILLION ANIMALS) 174 FIGURE 32 ANIMAL PARASITICIDES MARKET: GEOGRAPHIC SNAPSHOT 190 FIGURE 33 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA 192 FIGURE 34 NORTH AMERICA: PET POPULATION, 2024 192 FIGURE 35 NORTH AMERICA: ANIMAL PARASITICIDES MARKET SNAPSHOT 193 FIGURE 36 US: TOTAL PET HEALTH EXPENDITURE (2018–2024) 198 FIGURE 37 EUROPE: PET POPULATION (MILLION), 2023 206 FIGURE 38 ASIA PACIFIC: DOG POPULATION, BY COUNTRY, 2024 246 FIGURE 39 ASIA PACIFIC: CAT POPULATION, BY COUNTRY, 2024 246 FIGURE 40 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET SNAPSHOT 247 FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN ANIMAL PARASITICIDES MARKET (2023−2025) 328 FIGURE 42 ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025 329 FIGURE 43 US ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025 331 FIGURE 44 EUROPE ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025 331 FIGURE 45 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 333 FIGURE 46 ANIMAL PARASITICIDES MARKET: COMPANY FOOTPRINT 334 FIGURE 47 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 339 FIGURE 48 EV/EBITDA OF KEY VENDORS 342 FIGURE 49 5-YEAR STOCK BETA OF KEY VENDORS 342 FIGURE 50 BRAND/PRODUCT COMPARATIVE ANALYSIS 343 FIGURE 51 ZOETIS INC.: COMPANY SNAPSHOT (2025) 348 FIGURE 52 MERCK & CO., INC.: COMPANY SNAPSHOT (2025) 354 FIGURE 53 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2025) 360 FIGURE 54 ELANCO: COMPANY SNAPSHOT (2025) 365 FIGURE 55 VIRBAC: COMPANY SNAPSHOT (2025) 372 FIGURE 56 VETOQUINOL: COMPANY SNAPSHOT (2025) 380 FIGURE 57 KRKA, D. D., NOVO MESTO: COMPANY SNAPSHOT (2025) 391 FIGURE 58 ECO - ANIMAL HEALTH LTD.: COMPANY SNAPSHOT (2025) 394 FIGURE 59 OUROFINO SAÚDE ANIMAL: COMPANY SNAPSHOT (2025) 398 FIGURE 60 ANIMAL PARASITICIDES MARKET: RESEARCH DESIGN 412 FIGURE 61 PRIMARY SOURCES 414 FIGURE 62 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE) 416 FIGURE 63 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE) 417 FIGURE 64 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 417 FIGURE 65 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 418 FIGURE 66 REVENUE SHARE ANALYSIS ILLUSTRATION: ZOETIS, INC. 419 FIGURE 67 REVENUE ANALYSIS OF TOP FIVE COMPANIES: ANIMAL PARASITICIDES MARKET (2025) 419 FIGURE 68 ANIMAL PARASITICIDES MARKET: DEMAND-SIDE ANALYSIS 421 FIGURE 69 TOP-DOWN APPROACH 421 FIGURE 70 BOTTOM-UP APPROACH 422 FIGURE 71 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ANIMAL PARASITICIDES MARKET (2026–2031) 423 FIGURE 72 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 423 FIGURE 73 MARKET DATA TRIANGULATION METHODOLOGY 425

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們